UEEC: This is a SOLID company with a superior management team prudently guiding its premier hemostatic device, Hemostyp, through the arduous and complex FDA clinical evaluation and approval process that will allow for the use of its product in a surgical setting.
Once completed, the share value of United Health Products will increase EXPONENTIALLY to many multiples of its current trading price.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.